[ad_1]
July 25, 2018
ART recommended for almost all HIV-infected subjects; should be started as soon as possible after the diagnosis.
HealthDay News – Recommendations for antiretroviral therapy (ART) have been updated for people at risk or living with HIV; The recommendations of the International Antiviral Society-USA Panel of 2018 are published in the July 1945 issue of the Journal of the American Medical Association .
Michael S. Saag, MD, of the University of Alabama at Birmingham, and his colleagues developed new update recommendations for 2018 using evidence collected since the recommendations of the Institute. International Antiviral Society-USA 2016.
The authors note that for almost all HIV-infected individuals, ART is recommended as soon as possible after the diagnosis of HIV. For initial therapy, an integrase strand transfer inhibitor plus 2 nucleoside reverse transcriptase inhibitors is generally recommended; the choice of treatment must be guided by the particular circumstances of the patient. At specific points before and during antiretroviral treatment, CD4 count, HIV RNA level, genotype and other laboratory tests for general health and co-infection are recommended. Treatment history, tolerability, adherence, and history of drug resistance should be badessed if a change in diet is indicated; for a new diet, two or three active drugs are recommended. For all those who have already been badually active, the HIV test is recommended at least once, and the test is recommended more often for those who are at risk for infection. For individuals at risk, pre-exposure prophylaxis with tenofovir disoproxil / emtricitabine fumarate and appropriate monitoring is recommended.
"Advances in antiretroviral prevention and treatment continue to improve clinical management and outcomes for people at risk of HIV. , Write the authors
Several authors have revealed financial links with the pharmaceutical industry
Abstract / Full text
Editorial (a subscription or a payment may be required)
Scroll to the down to see the next article
[ad_2]
Source link
